THE SUCCESSFUL PREDICTION of objective remission in breast tumours following hormonal therapy may be improved if the functioning of the oestrogenreceptor (RE) system is assessed by the presence of both cytosol and nuclear RE (RE, and REN) (Garola & McGuire, 1977; Leake et al., 1981) , or both REc and progesterone receptor (RP) (Horwitz et al., 1975; McGuire et al., 1977; King et al., 1979) . However, there are certain practicalities that often preclude satisfactory receptor analyses, including insufficient tissue for saturation analysis and the instability of RP and REN under in vitro assay conditions. The regulation of REN binding in animal tissues may be controlled by a factor which activates REC, increasing its affinity for nuclear binding sites and transforming it to the REN (Thrower et al., 1976; White et al., 1978; Myatt et al., 1982) . The concentration of this putative activating factor is assessed by the binding of REC to artificial nuclear acceptor matrices including oligo-(dT)-cellulose and DNA-cellulose. Variations in the capability of breast-tumour REC to bind to DNA-cellulose, as described by Sato et al. (1981) , may influence the extent of REN binding. Breast tumours that contain REc which cannot be converted to REN exhibit a poor objective response to endocrine therapy (Kute et at., 1978) . In the present study the concentration of RE, and its ability to bind to oligo(dT)-cellulose has been Sixty-three biopsy specimens from 61 patients (22-79 years of age) with histologically confirmed primary breast carcinoma were studied. Thirty-eight patients (62.3%) were postmenopausal and the remaining 23 (37.7%) premenopausal.
Tumour tissue was stored in liquid N2 for not more than 2 months. Tissues were pulverized in a microdismembrator (Braun Instruments Ltd, West Germany) and resuspended in buffer (10 mm phosphate; 1.5 mM diK EDTA; 10 mm monothioglycerol (pH 7.4) containing 30% glycerol) to a concentration of 1:8 (w/v). Subsequent procedures were performed at 4°C. The suspension was stirred for 10 min, followed by centrifugation at 2000 g for 15 min to yield a nuclear pellet and supernatant (cytosol) fraction. REC and R.P were assayed using the method of King et al. (1979) (Siiteri & MacDonald, 1973) . The presence of REN4 in human breast tumours has been previously reported Kiang, 1977 , Laing et al., 1977 . The increase in the proportion of REN4 that occurs in the postmenopausal group is in agreement with Thorsen (1979) and may be explained by the nature of the ligand that occupies the REN. As oestrogens may be formed by breast-tumour tissue in situ (Miller & Forest, 1974; Adams & Li, 1975; Li et al., 1976 ) from precursors in plasma, a simplistic interpretation of the origin of REN based upon the nature of the circulating oestrogen may not be entirely valid. However, the change in content and proportion of REN4 in pre-and postmenopausal groups suggests that they are not simply a constitutive form of nuclear receptor. The low incidence of RP+ tumours in postmenopausal women may be related to the value of receptor content used in discriminating between tumours or, alternatively, to insufficient oestrogen stimulation in the postmenopausal patient (McGuire, 1980) . A positive correlation exists between RE content and response to endocrine therapy (McGuire, 1980; Lippman, 1980) with postmenopausal patients showing the most favourable response (Leake et al., 1981) . A better index of function may be the ratio RP/ REN, as proposed for the assessment of human endometrium (King & Whitehead, 1980) . The rationale that each parameter represents a functional component of the receptor system has been verified by the improved prediction rate for response to hormone therapy when receptor parameters were measured simultaneously. In our group of premenopausal patients (Table II) selecting REc+ and REN30+, or REC+ and REN4+, was associated with being RP+ (7/7 and 7/10 respectively). All tumours that were REc+ and positive for binding to oligo(dT)-cellulose were also RP+ (5/5). Binding to oligo(dT)-cellulose is therefore as good a parameter as REN content in predicting the presence of RP and hence response to hormone therapy.
In the postmenopausal REC+ tumours there was little correlation between binding to oligo(dT)-cellulose or REN content and RP positivity. In contrast to the 78% of REC+ tumours which were positive for binding to oligo(dT)-cellulose, only 37%
were RP+. In view of the apparent association between RE content and response to therapy, the postmenopausal group would be expected to have the better prognosis. However, on the basis of the simultaneous incidence of REC and RP, the postmenopausal group (37%) appears less favourable than the premenopausal group (68%). Binding to oligo(dT)-cellulose in RE+ tumours (50% pre-, 78% postmenopausal) may be a better determinant of receptor function, and hence response to hormone therapy.
